Impact of In-Hospital Major Bleeding on Late Clinical Outcomes After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Impact of In-Hospital Major Bleeding on Late Clinical Outcomes After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Published:2011-10 Issue:17 Volume:58 Page:1750-1756
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Suh Jung-Won,Mehran Roxana,Claessen Bimmer E.,Xu Ke,Baber Usman,Dangas George,Parise Helen,Lansky Alexandra J.,Witzenbichler Bernhard,Grines Cindy L.,Guagliumi Giulio,Kornowski Ran,Wöhrle Jochen,Dudek Dariusz,Weisz Giora,Stone Gregg W.

Funder

Boston Scientific

Medicines Company

The Medicines Co.

Sanofi-Aventis

Bristol-Myers Squibb

Medtronic and Boston Scientific

Abbott Vascular

Abbott

Adamed

AstraZeneca

Biotronik

Balton

Bayer

BBraun

BioMatrix

Boehringer Ingelheim

Cordis

Cook Eli Lilly

EuroCor

Glaxo

Invatec

Medtronic

MSD

Nycomed

Orbus-Neich

Pfizer

Possis

Promed

Siemens

Solvay

Terumo

Tyco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference13 articles.

1. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes;Eikelboom;Circulation,2006

2. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes;Rao;Am J Cardiol,2005

3. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial;Manoukian;J Am Coll Cardiol,2007

4. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial;Mehran;Lancet,2009

5. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point;Ndrepepa;J Am Coll Cardiol,2008

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bivalirudin Versus Heparin Monotherapy in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Study-level Meta-analysis of Randomized Controlled Trials;Cardiovascular Drugs and Therapy;2024-07-30

2. Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?;Interventional Cardiology: Reviews, Research, Resources;2023-06-13

3. Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction;American Heart Journal;2023-04

4. Exploring the potential cost-effectiveness of a novel platelet assay for guiding dual antiplatelet therapy duration in acute coronary syndrome patients following percutaneous coronary intervention;Coronary Artery Disease;2022-11-22

5. Triple Antiplatelet Therapy with Cilostazol and Favorable Early Clinical Outcomes after Acute Myocardial Infarction Compared to Dual Antiplatelet Therapy with Standard or Potent P2Y12 Inhibitors;Journal of Clinical Medicine;2022-11-21